CN102671022B - Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps - Google Patents
Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps Download PDFInfo
- Publication number
- CN102671022B CN102671022B CN201210155270.0A CN201210155270A CN102671022B CN 102671022 B CN102671022 B CN 102671022B CN 201210155270 A CN201210155270 A CN 201210155270A CN 102671022 B CN102671022 B CN 102671022B
- Authority
- CN
- China
- Prior art keywords
- percent
- soup
- radix
- heat
- honeysuckle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000014347 soups Nutrition 0.000 title claims abstract description 11
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 title claims abstract description 8
- 208000005647 Mumps Diseases 0.000 title abstract description 12
- 208000010805 mumps infectious disease Diseases 0.000 title abstract description 12
- 244000068988 Glycine max Species 0.000 title abstract description 8
- 235000010469 Glycine max Nutrition 0.000 title abstract description 8
- 230000009967 tasteless effect Effects 0.000 title abstract description 8
- 241000205585 Aquilegia canadensis Species 0.000 title abstract 3
- 235000014676 Phragmites communis Nutrition 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 17
- 239000000706 filtrate Substances 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 241000255791 Bombyx Species 0.000 claims description 5
- 241000959626 Calvatia Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 239000010231 banlangen Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000008961 swelling Effects 0.000 abstract description 11
- 208000011580 syndromic disease Diseases 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 241000133231 Marshallia caespitosa Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 17
- 235000019634 flavors Nutrition 0.000 description 17
- 210000004072 lung Anatomy 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 6
- 206010068319 Oropharyngeal pain Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 201000007100 Pharyngitis Diseases 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000003681 parotid gland Anatomy 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 201000000297 Erysipelas Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 206010014599 encephalitis Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 241000711386 Mumps virus Species 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 201000011475 meningoencephalitis Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 201000005737 orchitis Diseases 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010034023 Parotid gland enlargement Diseases 0.000 description 1
- JJVGFDTWFVSBIM-UHFFFAOYSA-N Phillyrin Natural products COc1ccc(cc1OC)C2OCC3C2COC3c4ccc(OC)c(OC5OC(CO)C(O)C(O)C5O)c4 JJVGFDTWFVSBIM-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000612119 Samolus Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 208000005963 oophoritis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000003481 parotid region Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000003670 sublingual gland Anatomy 0.000 description 1
- 210000001913 submandibular gland Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210155270.0A CN102671022B (en) | 2012-05-08 | 2012-05-08 | Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210155270.0A CN102671022B (en) | 2012-05-08 | 2012-05-08 | Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102671022A CN102671022A (en) | 2012-09-19 |
CN102671022B true CN102671022B (en) | 2014-07-16 |
Family
ID=46804006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210155270.0A Active CN102671022B (en) | 2012-05-08 | 2012-05-08 | Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102671022B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103908735B (en) * | 2014-03-04 | 2015-09-30 | 太仓市伟基生物科技有限公司 | A kind of gauze type Chinese medicine headgear preventing and treating mumps |
CN103933396A (en) * | 2014-04-22 | 2014-07-23 | 湖州康企药业有限公司 | Heat-clearing toxicity-removing oral solution |
CN104721296A (en) * | 2015-04-03 | 2015-06-24 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine used for treating parotitis |
CN105395957A (en) * | 2015-12-31 | 2016-03-16 | 张明 | Traditional Chinese medicine composition for treating livestock mumps |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1473604A (en) * | 2003-08-08 | 2004-02-11 | 冉光奇 | Capsule for treating epidemic parotitis |
-
2012
- 2012-05-08 CN CN201210155270.0A patent/CN102671022B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1473604A (en) * | 2003-08-08 | 2004-02-11 | 冉光奇 | Capsule for treating epidemic parotitis |
Non-Patent Citations (2)
Title |
---|
刘绍贵主编.羚羊感冒胶囊.《中药处方手册》.湖南科学技术出版社,2003,382. * |
林才生,宋士山主编.小儿流行性腮腺炎.《中医临床专验良方3300首》.中国中医药出版社,1998,396. * |
Also Published As
Publication number | Publication date |
---|---|
CN102671022A (en) | 2012-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
CN102671022B (en) | Honeysuckle, weeping forsythiae, fructus arctii, tasteless preserved soybean and reed rhizome soup for treating mumps | |
CN103830636A (en) | Pharmaceutical composition for treating bronchitis and asthma | |
CN103610885B (en) | Traditional Chinese medicine preparation for treating rash | |
CN104784548A (en) | Traditional Chinese medicine composition for treating cough and application thereof | |
CN103751638A (en) | Acne damp-clearing complexing agent and preparation method thereof | |
CN104257778B (en) | A kind of Chinese medicine treating rheumatic arthritis | |
CN103505530B (en) | Traditional Chinese medicine composition for treating variability measles | |
CN104161878A (en) | Traditional Chinese medicine preparation for treating lung abscess | |
CN102727738A (en) | Traditional Chinese medicine composition used for treating chronic obstructive pulmonary disease, and preparation method thereof | |
CN103610892A (en) | Traditional Chinese medicine powder for treating dental ulcers | |
CN103566248B (en) | The Chinese medicine for the treatment of mumps | |
CN104784394A (en) | Traditional Chinese medicine sachet with capability of improving immunity and preparation method of traditional Chinese medicine sachet | |
CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
CN103463444B (en) | Traditional Chinese medicine composition for treating phlegm stagnation cross-resistance type acnes | |
CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
CN102125620B (en) | Traditional Chinese medicinal preparation for treating erysipelas | |
CN105169324A (en) | Chinese herba preparation for prevention and treatment of common cold due to wind-cold | |
CN104383325A (en) | Oral liquid for treating amygdalitis | |
CN104771498A (en) | Traditional Chinese medicine composition for treating mumps caused by accumulated toxic heat | |
CN104474154A (en) | Traditional Chinese medicine for treating cold fever and preparation method of traditional Chinese medicine | |
CN104398724A (en) | Preparation method for traditional Chinese medicine preparation treating pemphigus | |
CN103989885A (en) | Traditional Chinese medicine for treating chronic pelvic inflammation | |
CN103800890A (en) | Medicine for treating menoxenia and preparation method thereof | |
CN104666454A (en) | Plaster for preventing and treating deficiency-type carbuncle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WANG LIHUA Free format text: FORMER OWNER: YU LIHUA Effective date: 20141224 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264400 WEIHAI, SHANDONG PROVINCE TO: 637400 NANCHONG, SICHUAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141224 Address after: 637400 Langzhong city of Sichuan province Shou Shan Si Street No. 8 4 Building 2 unit 2 Building No. 2 Patentee after: Wang Lihua Address before: 264400 Wendeng, Shandong, Zhejiang Province, East Hill Road, No. 3, Wendeng Central Hospital, Weihai Patentee before: Yu Lihua |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151224 Address after: 225500 No. 1 Su Zhong Road, Jiangyan District, Jiangsu, Taizhou Patentee after: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. Address before: 637400 Langzhong city of Sichuan province Shou Shan Si Street No. 8 4 Building 2 unit 2 Building No. 2 Patentee before: Wang Lihua |
|
CP01 | Change in the name or title of a patent holder |
Address after: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee after: Suzhong Pharmaceutical Group Co.,Ltd. Address before: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee before: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |